ANI Pharmaceuticals ANIP Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's investing cash flow?
- ANI Pharmaceuticals (ANIP) reported investing cash flow of -$11.32M in Q1 2026.
- How has ANI Pharmaceuticals's investing cash flow changed year-over-year?
- ANI Pharmaceuticals's investing cash flow increased by 42.9% year-over-year, from -$19.85M to -$11.32M.
- What is the long-term trend for ANI Pharmaceuticals's investing cash flow?
- Over 4 years (2021 to 2025), ANI Pharmaceuticals's investing cash flow has grown at a -24.5% compound annual growth rate (CAGR), from -$105.48M to -$34.32M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.